Portage Biotech Inc PRTG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
-
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
-
Portage Biotech Announces $6.0 Million Registered Direct Offering
-
Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference
-
Portage Biotech in Keytruda Collaboration With Merck
-
Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid Tumors
Trading Information
- Previous Close Price
- $1.33
- Day Range
- $1.31–1.40
- 52-Week Range
- $1.21–7.67
- Bid/Ask
- $1.33 / $1.35
- Market Cap
- $26.69 Mil
- Volume/Avg
- 7,282 / 27,684
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 7
- Website
- https://www.portagebiotech.com
Valuation
Metric
|
PRTG
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.53 |
Price/Sales | — |
Price/Cash Flow | — |
Financial Strength
Metric
|
PRTG
|
---|---|
Quick Ratio | 1.25 |
Current Ratio | 2.00 |
Interest Coverage | −7,945.31 |
Profitability
Metric
|
PRTG
|
---|---|
Return on Assets (Normalized) | −6.83% |
Return on Equity (Normalized) | −10.67% |
Return on Invested Capital (Normalized) | −8.93% |
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jxzdn | $456.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Jjzzbkj | $91.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Lrkltq | $89.8 Bil | |
SGEN
| Seagen Inc Ordinary Shares | Frnbyt | $40.2 Bil | |
MRNA
| Moderna Inc | Rzg | $29.6 Bil | |
ARGX
| argenx SE ADR | Jfyd | $26.4 Bil | |
BNTX
| BioNTech SE ADR | Mtwt | $23.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Yrmlf | $21.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bmclxp | $17.2 Bil | |
INCY
| Incyte Corp | Pmrhhzh | $12.2 Bil |